Maharashtra, India

Ganesh Bhausaheb Gudade

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 9.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Maharashtra, IN (2016)
  • Pune, IN (2022 - 2024)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: **Ganesh Bhausaheb Gudade: Innovator in PRMT5 Inhibitor Compounds**

Introduction

Ganesh Bhausaheb Gudade is a noteworthy inventor based in Maharashtra, India. He holds three patents that showcase his innovative contributions to the field of pharmaceutical sciences. His research primarily focuses on developing compounds that can be utilized for treating diseases associated with specific enzymes.

Latest Patents

One of his latest notable inventions is related to substituted bicyclic heterocyclic compounds that act as PRMT5 inhibitors. This invention aims to address medical conditions linked to the overexpression of the PRMT5 enzyme. It provides a comprehensive understanding of the compounds, including their formula (I), pharmaceutically acceptable salts, and potential pharmaceutical compositions. Furthermore, the invention details methods for treating diseases, disorders, or conditions that arise from PRMT5 overactivity.

Career Highlights

Ganesh has had a significant professional journey, with experience in reputable companies such as Lupin, Inc. and Lupin Atlantis Holdings SA. His work in these organizations showcases his commitment to pharmaceutical advancements and innovative research.

Collaborations

Throughout his career, Ganesh has collaborated with skilled professionals such as Prathap Sreedharan Nair and Mahadeo Bhaskar Tryambake. These associations reflect a collaborative approach in research that enhances knowledge-sharing and innovation.

Conclusion

Ganesh Bhausaheb Gudade continues to make strides in the pharmaceutical industry with his unique inventions, especially in the realm of PRMT5 inhibitors. His ongoing contributions are expected to pave the way for new treatments and enhance the quality of life for patients suffering from related diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…